We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 61.50 | 61.00 | 62.00 | 61.50 | 61.00 | 61.50 | 6,432 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 29.49M | -302k | -0.0043 | -143.02 | 43.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/1/2015 13:16 | A severe lack of interest here, but there is a little bit of interest elsewhere! Lack of info doesn't help, does it?😫 | rayrac | |
17/12/2014 16:24 | bobs, that was good timing. By the time I got things together it was 20p to buy. Odell made much during the recent presentation, of the fact that our NHS clinical trial dermis patients in the UK were a truly random selection, with one man having had a non-healing wound for 40 years. The US Doctors involved with their trial, were amazed that the co had included such difficult cases. It seems that some of the folk being treated with Dermapure now are those that have been failed by competitors products. Many are making good progress. | bamboo2 | |
17/12/2014 14:50 | FYI bb2, tradeplan executed @ 19.85 (£3595) on my ISA account this morning. Ideally want to see the first complete heal case study from a one of those early U.S practioner's now. | bobsgonnamakemerich | |
17/12/2014 11:41 | Late trade of 200k at 19.5 just reported, must be responsible for the drop earlier. Wonder I f I can top up under 20p? | bamboo2 | |
17/12/2014 09:13 | Listened to the Webcast. Very little new to add to the CMD. Significant interest in the Heart Valve product has been recieved from da Costas presentations. Potential new products mentioned are a hip arthroscopy repair involving Osteo/cartilage plugs. I think Ingham and Fisher have been working on this idea for some time with dCell Meniscus. Interestingly, Woodford added about a week after this presentation. | bamboo2 | |
10/12/2014 22:36 | Link for webcast from Jefferies 2014 Global Healthcare Conference: Currently, I can't get the webcast to play consistently, but the slides are viewable. | bamboo2 | |
05/12/2014 11:33 | I suspect Woodford will add if price drifts below his buy-in price. | igbertsponk | |
05/12/2014 11:31 | Thanks, bamboo. Also thanks for the excellent research you post here. Agree chart looks drifty down in short term but hoping news will reverse that in good time. | luminoso | |
05/12/2014 10:13 | luminoso, welcome. Chart is not looking too hot, but share price does look to offer a good entry point. Woodfords new interest here is positive, and I prefer to see him as a significant holder than Griffiths. img src="http://uk.advfn | bamboo2 | |
04/12/2014 12:45 | The trades of 20.75 and above are buys today, possibly even the 20.5 trades, as buy price has been around or below the bid for days on most quotes I have had. Nice 220k buy also. Not mine, sadly, but I do have a foot in the door now. | luminoso | |
01/12/2014 17:55 | As at 1 December 2014, shareholders holding more than 3% of the share capital of Tissue Regenix Group Plc are: • Invesco Limited - 27.88% [Invesco formerly held 29%, implying that WIM originally inherited 1.12% on behalf of St James Place] • Techtran Group Limited - 13.74% [aka ipo group] • WIM [WOODFORD] on behalf of St James Place 12.46% [81,478,587][Purchas • NFU Mutual - 4.66% • University of Leeds - 5.19% • Ballie Gifford & Co Ltd - 5.64% [36,870,574] Adding. • IP Venture Fund - 3.79% [aka ipo group] • John Samuel [Chair] – 3.71% • Alan Miller [NED]– 3.29% Larger known shareholders as at 1 Dec 2014 - Approx - 80% Shares in issue 654,123,031 ordinary shares of 0.5p each ================== from ipo group half yr figs 28/08/14 [directors personal holdings in TRX] Alan Aubrey 2,389,259 0.4% Mike Townend 1,950,863 0.3% Greg Smith 175,359 <0.1% Charles Winward 482,236 <0.1% Bruce Smith 329,172 <0.1% Charles Winward resigned from the Board on 23 April 2014 [Could be a seller?] | bamboo2 | |
01/12/2014 10:52 | Confirmed it was Richard Griffiths who sold. Good news as it means Invesco wouldn't sell any of theirs to Woodford like they have with a lot of their investments. | igbertsponk | |
28/11/2014 17:23 | Woodford holds 81,478,587 or 12.46% presumably on behalf of St James Place. I'll amend the holdings list once we have confirmation of the seller. | bamboo2 | |
28/11/2014 15:25 | Mind you, if the price of oil remains around its present level... Then industry will benefit! | rayrac | |
28/11/2014 14:04 | This market is in a bad mood. Hope it doesn't extend itself, a growling bear? | rayrac | |
28/11/2014 11:35 | Validation! | rayrac | |
28/11/2014 10:31 | Brill news. Woodford has been taking chunks of Invesco holdings on other companies. Clearly they didn't want to sell here but he wants in anyway. | igbertsponk | |
28/11/2014 09:49 | Woodford announcing going through 12%. Did they take Griffiths holding ? Another rns surely due. | luminoso | |
28/11/2014 08:11 | Re, the Dcell Meniscus product. There are two new papers available, 1, Describes the UK patent 2, Gives a short history of the development of various previous attempts to create replacement menisci, and explains why our product is important. Titled, 'Current strategies in meniscal regeneration' | bamboo2 | |
26/11/2014 15:51 | If it is a Griffiths sale then I would welcome it. I've watched his holding style here and in other tech stocks and whilst I have no hard evidence, I believe he sells into share price rises, which serves to negate the benefit of good news. Hopefully we will see firmer, more patient hands, holding his shares. Can't complain at the lack of volume now. :-) There is a small amount of stock on loan, here is the link to a chart of short interest for trx. I can't post as I am black, but if any of you blues fancy posting this image? [ps, I'm not sure the link is correct, but it is viewable in post no 9 earlier in this thread] target='window'>h | bamboo2 | |
26/11/2014 12:50 | Well Invesco would perhaps sell to Woodford's new fund. Techtran have just raised another £100m so have no need of the cash. So I agree, looks like Richard Griffith. Perhaps selling for tax reasons as he may fear a Labour government would tax his gain. So running offshore with the moolah now. | igbertsponk | |
26/11/2014 12:49 | Just seen that Sharecast.com puts Richard Griffith's holding at 71,602,551. Don't need to be Sherlock Holmes on this one. Here's the link: | andrewbaker | |
26/11/2014 12:43 | 71602551/654120000 = 10.946393781% What's the odds that Richard Griffith just sold out, lol. | andrewbaker | |
26/11/2014 12:33 | Into a bidders hands perhaps? But the price isn't stellar! | rayrac | |
26/11/2014 11:32 | Can only be one of these three selling : Invesco Limited 27.88% Techtran Group Limited 13.74% Richard Griffiths 10.95% | igbertsponk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions